採納股份(301122.SZ)IPO擬發行2350.88萬股 1月13定價、17日申購
格隆匯1月10日丨採納股份(301122.SZ)披露招股意向書,此次擬公開發行股票2350.88萬股,佔發行後公司總股本的25%,發行後公司總股本為9403.5122萬股;此次發行全部為新股發行,不涉及原股東公開發售股份。
其中,初始戰略配售發行數量為117.544萬股,佔此次發行數量的5.00%。回撥機制啟動前,此次發行網下初始發行數量為1563.336萬股,佔扣除初始戰略配售數量後發行數量的70.00%;網上初始發行數量為670萬股,佔扣除初始戰略配售數量後發行數量的30.00%。
此次發行初步詢價時間為2022年1月12日,2022年1月13日確定發行價格,網上網下申購日期為2022年1月17日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.